Ligand Pharmaceuticals (LGND) Debt by Year
Ligand Pharmaceuticals Inc. held $174.9M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Ligand Pharmaceuticals Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
LGND Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | N/A | N/A | N/A | $0-100.0% | $320.7M-27.5% | $442.3M-30.8% | $639.0M+4.8% | $609.9Mn/m | $0 | N/A | $0-100.0% | $195.9M | N/A | $27.5M | N/A |
| Cash & Equivalents | $174.9M+141.9% | $72.3M+215.0% | $23.0M-49.0% | $45.0M+130.5% | $19.5M-59.0% | $47.6M-33.4% | $71.5M-38.9% | $117.2M+468.2% | $20.6M+10.0% | $18.8M-80.8% | $97.4M-39.2% | $160.2M+1276.4% | $11.6M-6.0% | $12.4M+75.8% | $7.0M |
LGND Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $679.9M | $1.1B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $56.0M-59.9% | $1.0B+1387.7% | $115.1M+139.8% | $174.9M+141.9% | $139.4M+119.1% | $67.7M+273.1% | $48.0M-4.2% | $72.3M+215.0% | $63.6M+230.1% | $18.1M-36.2% | $50.1M-43.5% | $23.0M-49.0% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Ligand Pharmaceuticals Inc. financials
Frequently Asked Questions
What was Ligand Pharmaceuticals Inc.'s long-term debt in fiscal year 2025?
Ligand Pharmaceuticals Inc. held $174.9M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period.
What was Ligand Pharmaceuticals Inc.'s long-term debt in the most recent quarter?
Ligand Pharmaceuticals Inc. (LGND) reported $679.9M in long-term debt in Q3 2026.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Ligand Pharmaceuticals Inc. (LGND) reported on that line in every period on record.